Are Circulating Tumor Cells (CTCs) Ready for Clinical Use in Breast Cancer? An Overview of Completed and Ongoing Trials Using CTCs for Clinical Treatment Decisions

by Fabienne Schochter, Thomas W. P. Friedl, Amelie deGregorio, Sabrina Krause, Jens Huober, Brigitte Rack, Wolfgang Janni
Published 2019-11-01

53BP1 Accumulation in Circulating Tumor Cells Identifies Chemotherapy-Responsive Metastatic Breast Cancer Patients

by Fabienne Schochter, Kim Werner, Cäcilia Köstler, Anke Faul, Marie Tzschaschel, Barbara Alberter, Volkmar Müller, Hans Neubauer, Tanja Fehm, Thomas W.P. Friedl, Bernhard Polzer, Wolfgang Janni, Brigitte Rack, Lisa Wiesmüller
Published 2020-04-01

Evaluation of Two Different Analytical Methods for Circulating Tumor Cell Detection in Peripheral Blood of Patients with Primary Breast Cancer

by B. A. S. Jaeger, J. Jueckstock, U. Andergassen, J. Salmen, F. Schochter, V. Fink, M. Alunni-Fabbroni, M. Rezai, Th. Beck, M. W. Beckmann, K. Friese, T. W. P. Friedl, W. Janni, B. Rack
Published 2014-01-01

Estrogen Receptor and HER2 Status on Disseminated Tumor Cells and Primary Tumor in Patients with Early Breast Cancer

by Bernadette A.S. Jäger, Charlotte Finkenzeller, Carolin Bock, Leonie Majunke, Julia K. Jueckstock, Ulrich Andergassen, Julia K. Neugebauer, Aurelia Pestka, Thomas W.P. Friedl, Udo Jeschke, Wolfgang Janni, Sophie F. Doisneau-Sixou, Brigitte K. Rack
Published 2015-12-01

Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients

by Marianna Alunni-Fabbroni, Leonie Majunke, Elisabeth K. Trapp, Marie Tzschaschel, Sven Mahner, Peter A. Fasching, Tanja Fehm, Andreas Schneeweiss, Thomas Beck, Ralf Lorenz, Thomas W. P. Friedl, Wolfgang Janni, Brigitte Rack, on behalf of the SUCCESS Study Group
Published 2018-02-01

The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer: A translational research project of a prospective randomized phase III trial.

by B A S Jaeger, J Neugebauer, U Andergassen, C Melcher, F Schochter, D Mouarrawy, G Ziemendorff, M Clemens, E V Abel, G Heinrich, K Schueller, A Schneeweiss, P Fasching, M W Beckmann, Ch Scholz, T W P Friedl, K Friese, K Pantel, T Fehm, W Janni, B Rack
Published 2017-01-01

Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer—results from the randomized phase III SUCCESS-A trial

by Amelie de Gregorio, Lothar Häberle, Peter A. Fasching, Volkmar Müller, Iris Schrader, Ralf Lorenz, Helmut Forstbauer, Thomas W. P. Friedl, Emanuel Bauer, Nikolaus de Gregorio, Miriam Deniz, Visnja Fink, Inga Bekes, Ulrich Andergassen, Andreas Schneeweiss, Hans Tesch, Sven Mahner, Sara Y. Brucker, Jens-Uwe Blohmer, Tanja N. Fehm, Georg Heinrich, Krisztian Lato, Matthias W. Beckmann, Brigitte Rack, Wolfgang Janni
Published 2020-10-01